A carregar...
Atherosclerosis severity is not affected by a deficiency in IL‐33/ST2 signaling
Interleukin (IL)‐33 is a cytokine of the IL‐1 family, which signals through the ST2 receptor. Previous work demonstrated that the systemic administration of recombinant IL‐33 reduces the development of atherosclerosis in apolipoprotein E‐deficient (ApoE(−/−)) mice by inducing a Th1‐to‐Th2 shift. The...
Na minha lista:
| Publicado no: | Immun Inflamm Dis |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4578523/ https://ncbi.nlm.nih.gov/pubmed/26417439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/iid3.62 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|